Walleye Capital’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.14M | Sell |
243,275
-448,444
| -65% | -$2.09M | ﹤0.01% | 793 |
|
|
2025
Q1 | $3.8M | Buy |
+691,719
| New | +$3.8M | 0.02% | 422 |
|
|
2024
Q4 | – | Sell |
-1,121,738
| Closed | -$3.2M | – | 2706 |
|
|
2024
Q3 | $3.2M | Buy |
+1,121,738
| New | +$3.2M | 0.01% | 577 |
|
|
2024
Q1 | – | Sell |
-35,927
| Closed | -$84.4K | – | 3023 |
|
|
2023
Q4 | $84.4K | Sell |
35,927
-88,763
| -71% | -$209K | ﹤0.01% | 1637 |
|
|
2023
Q3 | $232K | Buy |
+124,690
| New | +$232K | ﹤0.01% | 1433 |
|
|
2020
Q2 | – | Sell |
-113,269
| Closed | -$221K | – | 805 |
|
|
2020
Q1 | $221K | Buy |
+113,269
| New | +$221K | 0.05% | 280 |
|